Pages

Showing posts with label longevity. Show all posts
Showing posts with label longevity. Show all posts

Saturday, October 1, 2022

Causal analysis identifies small HDL particles and physical activity as key determinants of longevity of older adults [Scholarly Article - The Lancet (eBioMedicine), September 2022]

Title:
Causal analysis identifies small HDL particles and physical activity as key determinants of longevity of older adults
 
Authors:
Virginia Byers Kraus, Sisi Ma, Roshan Tourani ,Gerda G. Fillenbaum, Bruce M. Burchett, Daniel C. Parker, William E. Kraus, Margery A. Connelly, James D. Otvos, Harvey Jay Cohen, Melissa C. Orenduff ,Carl F. Pieper, Xin Zhang & Constantin F. Aliferis
 
Publication:
The Lancet (eBioMedicine), 28 September 2022
 
Summary 
Background 
The hard endpoint of death is one of the most significant outcomes in both clinical practice and research settings. Our goal was to discover direct causes of longevity from medically accessible data. 
 
Methods 
Using a framework that combines local causal discovery algorithms with discovery of maximally predictive and compact feature sets (the “Markov boundaries” of the response) and equivalence classes, we examined 186 variables and their relationships with survival over 27 years in 1507 participants, aged ≥71 years, of the longitudinal, community-based D-EPESE study. 
 
Findings 
As few as 8-15 variables predicted longevity at 2-, 5- and 10-years with predictive performance (area under receiver operator characteristic curve) of 0·76 (95% CIs 0·69, 0·83), 0·76 (0·72, 0·81) and 0·66 (0·61, 0·71), respectively. Numbers of small high-density lipoprotein particles, younger age, and fewer pack years of cigarette smoking were the strongest determinants of longevity at 2-, 5- and 10-years, respectively. Physical function was a prominent predictor of longevity at all time horizons. Age and cognitive function contributed to predictions at 5 and 10 years. Age was not among the local 2-year prediction variables (although significant in univariable analysis), thus establishing that age is not a direct cause of 2-year longevity in the context of measured factors in our data that determine longevity. 
 
Interpretation 
The discoveries in this study proceed from causal data science analyses of deep clinical and molecular phenotyping data in a community-based cohort of older adults with known lifespan. 
 

Thursday, June 30, 2022

Secrets of aging revealed in largest study on longevity, aging in reptiles and amphibians [ScienceDaily, June 2022]

Title:
Secrets of aging revealed in largest study on longevity, aging in reptiles and amphibians
 
Source:
Penn State
 
Published:
ScienceDaily, 23 June 2022
 
Summary:
An international team of 114 scientists reports the most comprehensive study of aging and longevity to date of reptiles and amphibians worldwide. Among their many findings, they document for the first time that turtles, crocodilians and salamanders have particularly low aging rates and extended lifespans for their sizes. The team also finds that protective phenotypes, such as the hard shells of most turtle species, contribute to slower aging, and in some cases even 'negligible aging' -- or lack of biological aging.

Monday, April 4, 2022

How many steps per day are needed for longevity? Fewer than 10 000, says large study

Title:
How many steps per day are needed fro longevity? Fewer than 10 000, says large study

Author:
Zakiyah Ebrahim

Published:
health 24, 9 March 2022

From the article:
* Achieving 10 000 steps a day has long been seen as a benchmark for fitness and health.  
 
* However, more and more evidence is showing that one can aim for fewer steps and still achieve longevity. 
 
* A meta-analysis suggests that especially older adults can make do with fewer than 10 000 steps per day.  

Tuesday, February 8, 2022

Do you know about the Dog Aging Project?

Title:
Dog Aging Project
 
Published:
Dog Aging Project, 2022
 
From the Dog Aging Project website:
The goal of the Dog Aging Project is to understand how genes, lifestyle, and environment influence aging. We want to use that information to help pets and people increase healthspan, the period of life spent free from disease.
 
Note:
The Dog Aging Project is supported by U19 grant AG057377 from the National Institute on Aging, a part of the National Institutes of Health, and by private donations.
 

Monday, January 3, 2022

10 Longevity Resolutions for 2022 [Peter H. Diamandis blog, January 2021]

Title:
10 Longevity Resolutions for 2022

Author:
Peter H. Diamandis
 
Published:
Peter H. Diamandis Blog, 2 January 2022

From the blog post:
Happy 2022!  
 
Nothing is more important than your Mindset in the new year....  
 
Today I’m going to share my Top 10 Longevity Resolutions to keep you healthy and thriving in 2022.  
 
During this decade of extra-ordinary biotech breakthroughs, your goal is to live healthy enough, to intercept those age-reversal technologies heading our way.  
 
There are important things you can do right now.

Wednesday, December 23, 2020

2020 in Neuroscience, Longevity, and AI—and What’s to Come [SingularityHub, 22 December 2020]

Title:
2020 in Neuroscience, Longevity, and AI—and What’s to Come
 
Author:
Shelly Fan
 
Published:
SingularityHub, 22 December 2020
 
From the article:
Why we age is extremely complex. So are methods that try to prevent age-related diseases, or slow the aging process itself. This nth-dimensional complexity almost dictates that longevity research needs to self-segregate into lanes.

Tuesday, November 24, 2020

Tel Aviv University - Human ageing process biologically reversed in world first

Title:
Human ageing process biologically reversed in world first
 
Author:
Sarah Knapton
 
Published:
Yahoo!News, 18 November 2020
Click here to read
 
From the article:
Now scientists at Tel Aviv University have shown that giving pure oxygen to older people while in a hyperbaric chamber increased the length of their telomeres by 20 per cent, a feat that has never been achieved before.

Thursday, June 25, 2020

Peter Diamandis (tech blog, 21 June 2020) - Longevity & Vitality - A Renaissance of Drugs and Genomics

Title:
Longevity & Vitality - A Renaissance of Drugs and Genomics

Blog owner post:
Peter Diamandis

Published:
tech blog, 21 June 2020
https://www.diamandis.com/blog/longevity-drugs-and-genomics

From the blog post:
The causes of aging are extremely complex and unclear.

But with longevity clinical trials increasing 3.5X, from 73 in 2012 to over 258 in 2019, more answers — and questions — are emerging than ever before.

With the dramatic demonetization of genome reading and editing over the past decade, and Big Pharma, startups, and the FDA starting to face aging as a disease, we are starting to turn those answers into practical ways to extend our healthspan.

In this blog, I will explore how genome sequencing and editing, along with new classes of anti-aging drugs, are augmenting our biology to further extend our healthy lives.

Wednesday, January 1, 2020

VIDEO (31:44) - Dr Aubrey de Grey: Investing in the Age of Longevity [8 December 2019]

From the description of the video:
"Dr Aubrey de Grey, CSO at the SENS Research Foundation speaking at Master Investor's Investing in the Age of Longevity 2019 event. Aubrey discusses Rejuvenation biotechnology and how it's track to become the biggest industry ever."

To watch this video:
https://lifeboat.com/blog/2019/12/dr-aubrey-de-grey-investing-in-the-age-of-longevity-2019